Cardiac and pulmonary late effects do not negatively influence performance status and non-relapse mortality of children surviving five yr after autologous hematopoietic cell transplantation: Report from the EBMT Paediatric Diseases and Late Effects Working Parties

Cornelio Uderzo, Marta Pillon, Gloria Tridello, Giorgio Dini, Christian Urban, Paola Corti, Felix Zintl, Franca Fagioli, Chiara Messina, Amparo Verdeguer, Maura Faraci, Sara Fedeli, Francesco Tana, André Tichelli, Jakob Passweg, Attilio Rovelli

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

The current prospective study dealt with clinical outcome associated with pulmonary and cardiac late effects of AuHCT in children with malignancies. We prospectively evaluated 58 children, utilizing pulmonary function tests and cardiac shortening fraction, performed in pre-AuHCT phase and then annually. The overall five-yr survival was 68%. The five-yr cumulative incidence of lung and cardiac function impairment in survivors was 21% in both cases. None of the patients presented with restrictive or obstructive pulmonary pathology at the last follow-up and performance status for all survivors, ranged from 90% to 100%. The cumulative incidence of non-relapse mortality was 12.6% (range 6.3-25.3%), whereas relapse mortality was 19.7% (range 11.6-33.5). In conclusion, our study shows no significant deterioration in post-AuHCT pulmonary and cardiac function and in particular, no negative impact of lung and heart late effects on performance status and non-relapse mortality.

Original languageEnglish
Pages (from-to)719-724
Number of pages6
JournalPediatric Transplantation
Volume13
Issue number6
DOIs
Publication statusPublished - Sep 2009

Fingerprint

Child Mortality
Cell Transplantation
Pediatrics
Lung
Survivors
Mortality
Respiratory Function Tests
Incidence
Prospective Studies
Pathology
Recurrence
Survival
Neoplasms

Keywords

  • Autologous hematopoietic cell transplantation
  • Cardiac late effects
  • Childhood
  • Performance status
  • Pulmonary

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Transplantation

Cite this

Cardiac and pulmonary late effects do not negatively influence performance status and non-relapse mortality of children surviving five yr after autologous hematopoietic cell transplantation : Report from the EBMT Paediatric Diseases and Late Effects Working Parties. / Uderzo, Cornelio; Pillon, Marta; Tridello, Gloria; Dini, Giorgio; Urban, Christian; Corti, Paola; Zintl, Felix; Fagioli, Franca; Messina, Chiara; Verdeguer, Amparo; Faraci, Maura; Fedeli, Sara; Tana, Francesco; Tichelli, André; Passweg, Jakob; Rovelli, Attilio.

In: Pediatric Transplantation, Vol. 13, No. 6, 09.2009, p. 719-724.

Research output: Contribution to journalArticle

Uderzo, Cornelio ; Pillon, Marta ; Tridello, Gloria ; Dini, Giorgio ; Urban, Christian ; Corti, Paola ; Zintl, Felix ; Fagioli, Franca ; Messina, Chiara ; Verdeguer, Amparo ; Faraci, Maura ; Fedeli, Sara ; Tana, Francesco ; Tichelli, André ; Passweg, Jakob ; Rovelli, Attilio. / Cardiac and pulmonary late effects do not negatively influence performance status and non-relapse mortality of children surviving five yr after autologous hematopoietic cell transplantation : Report from the EBMT Paediatric Diseases and Late Effects Working Parties. In: Pediatric Transplantation. 2009 ; Vol. 13, No. 6. pp. 719-724.
@article{de599c05401f4c7883c9fb0b74a857cb,
title = "Cardiac and pulmonary late effects do not negatively influence performance status and non-relapse mortality of children surviving five yr after autologous hematopoietic cell transplantation: Report from the EBMT Paediatric Diseases and Late Effects Working Parties",
abstract = "The current prospective study dealt with clinical outcome associated with pulmonary and cardiac late effects of AuHCT in children with malignancies. We prospectively evaluated 58 children, utilizing pulmonary function tests and cardiac shortening fraction, performed in pre-AuHCT phase and then annually. The overall five-yr survival was 68{\%}. The five-yr cumulative incidence of lung and cardiac function impairment in survivors was 21{\%} in both cases. None of the patients presented with restrictive or obstructive pulmonary pathology at the last follow-up and performance status for all survivors, ranged from 90{\%} to 100{\%}. The cumulative incidence of non-relapse mortality was 12.6{\%} (range 6.3-25.3{\%}), whereas relapse mortality was 19.7{\%} (range 11.6-33.5). In conclusion, our study shows no significant deterioration in post-AuHCT pulmonary and cardiac function and in particular, no negative impact of lung and heart late effects on performance status and non-relapse mortality.",
keywords = "Autologous hematopoietic cell transplantation, Cardiac late effects, Childhood, Performance status, Pulmonary",
author = "Cornelio Uderzo and Marta Pillon and Gloria Tridello and Giorgio Dini and Christian Urban and Paola Corti and Felix Zintl and Franca Fagioli and Chiara Messina and Amparo Verdeguer and Maura Faraci and Sara Fedeli and Francesco Tana and Andr{\'e} Tichelli and Jakob Passweg and Attilio Rovelli",
year = "2009",
month = "9",
doi = "10.1111/j.1399-3046.2008.01055.x",
language = "English",
volume = "13",
pages = "719--724",
journal = "Pediatric Transplantation",
issn = "1397-3142",
publisher = "Wiley-Blackwell",
number = "6",

}

TY - JOUR

T1 - Cardiac and pulmonary late effects do not negatively influence performance status and non-relapse mortality of children surviving five yr after autologous hematopoietic cell transplantation

T2 - Report from the EBMT Paediatric Diseases and Late Effects Working Parties

AU - Uderzo, Cornelio

AU - Pillon, Marta

AU - Tridello, Gloria

AU - Dini, Giorgio

AU - Urban, Christian

AU - Corti, Paola

AU - Zintl, Felix

AU - Fagioli, Franca

AU - Messina, Chiara

AU - Verdeguer, Amparo

AU - Faraci, Maura

AU - Fedeli, Sara

AU - Tana, Francesco

AU - Tichelli, André

AU - Passweg, Jakob

AU - Rovelli, Attilio

PY - 2009/9

Y1 - 2009/9

N2 - The current prospective study dealt with clinical outcome associated with pulmonary and cardiac late effects of AuHCT in children with malignancies. We prospectively evaluated 58 children, utilizing pulmonary function tests and cardiac shortening fraction, performed in pre-AuHCT phase and then annually. The overall five-yr survival was 68%. The five-yr cumulative incidence of lung and cardiac function impairment in survivors was 21% in both cases. None of the patients presented with restrictive or obstructive pulmonary pathology at the last follow-up and performance status for all survivors, ranged from 90% to 100%. The cumulative incidence of non-relapse mortality was 12.6% (range 6.3-25.3%), whereas relapse mortality was 19.7% (range 11.6-33.5). In conclusion, our study shows no significant deterioration in post-AuHCT pulmonary and cardiac function and in particular, no negative impact of lung and heart late effects on performance status and non-relapse mortality.

AB - The current prospective study dealt with clinical outcome associated with pulmonary and cardiac late effects of AuHCT in children with malignancies. We prospectively evaluated 58 children, utilizing pulmonary function tests and cardiac shortening fraction, performed in pre-AuHCT phase and then annually. The overall five-yr survival was 68%. The five-yr cumulative incidence of lung and cardiac function impairment in survivors was 21% in both cases. None of the patients presented with restrictive or obstructive pulmonary pathology at the last follow-up and performance status for all survivors, ranged from 90% to 100%. The cumulative incidence of non-relapse mortality was 12.6% (range 6.3-25.3%), whereas relapse mortality was 19.7% (range 11.6-33.5). In conclusion, our study shows no significant deterioration in post-AuHCT pulmonary and cardiac function and in particular, no negative impact of lung and heart late effects on performance status and non-relapse mortality.

KW - Autologous hematopoietic cell transplantation

KW - Cardiac late effects

KW - Childhood

KW - Performance status

KW - Pulmonary

UR - http://www.scopus.com/inward/record.url?scp=68849120961&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=68849120961&partnerID=8YFLogxK

U2 - 10.1111/j.1399-3046.2008.01055.x

DO - 10.1111/j.1399-3046.2008.01055.x

M3 - Article

C2 - 18992061

AN - SCOPUS:68849120961

VL - 13

SP - 719

EP - 724

JO - Pediatric Transplantation

JF - Pediatric Transplantation

SN - 1397-3142

IS - 6

ER -